Application 089397
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | Injectable; Injection | 0.2MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLYCOPYRROLATE | GLYCOPYRROLATE | Quinn Pharmaceuticals | e1ded8e0-c05b-4bf4-a129-57d1726af6ed | 2022-12-20 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 26cdd84d-ffa0-4e52-b359-4acef4bd8093 | 2022-11-10 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Camber Pharmaceuticals, Inc. | 4741be85-3abb-4545-aba9-281f64d210ec | 2022-07-13 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Novadoz Pharmaceuticals LLC | 98820c01-1853-45d8-9da5-875fcdf5f9ab | 2022-06-14 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Xiromed LLC | 29618edf-39b0-022a-9875-9d865450d318 | 2022-04-12 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Xiromed, LLC | f777c813-3232-d744-8bcf-58e86fb929bd | 2022-04-12 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 2022-03-23 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | d5a18d74-0d40-46e2-aa0a-41d18609a536 | 2022-03-04 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| glycopyrrolate | GLYCOPYRROLATE | BE Pharmaceuticals Inc. | d9df3900-a8c2-438b-8971-ba11ff91f90b | 2022-02-24 | Warnings, Adverse reactions | glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Somerset Therapeutics, LLC | a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6 | 2022-01-27 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | AuroMedics Pharma LLC | eaebb511-1738-4d11-b9bb-317a8d41316a | 2021-12-22 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Nivagen Pharmaceuticals, Inc. | 7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177 | 2021-10-29 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Alembic Labs LLC | db178372-51d2-4194-bbe2-da9acb1cfd53 | 2020-12-09 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Civica, Inc. | 9f7f1ebf-58e8-4ae7-8157-1595df8ad6f4 | 2020-02-26 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Dr. Reddy's Laboratories Limited | 725529e8-9c4b-4108-690a-e4f391439736 | 2016-11-15 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.